Citations (54)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Wael A. A. Fadaly, Mohamed T. M. Nemr, Taha H. Zidan, Fatma E. A. Mohamed, Marwa M. Abdelhakeem, Nour N. Abu Jayab, Hany A. Omar & Khaled R. A. Abdellatif. (2023) New 1,2,3-triazole/1,2,4-triazole hybrids linked to oxime moiety as nitric oxide donor selective COX-2, aromatase, B-RAFV600E and EGFR inhibitors celecoxib analogs: design, synthesis, anti-inflammatory/anti-proliferative activities, apoptosis and molecular modeling study. Journal of Enzyme Inhibition and Medicinal Chemistry 38:1.
Read now
Read now
Wael A. A. Fadaly, Taha H. Zidan, Nesma M. Kahk, Fatma E. A. Mohamed, Marwa M. Abdelhakeem, Rehab G. Khalil & Mohamed T. M. Nemr. (2023) New pyrazolyl-thiazolidinone/thiazole derivatives as celecoxib/dasatinib analogues with selective COX-2, HER-2 and EGFR inhibitory effects: design, synthesis, anti-inflammatory/anti-proliferative activities, apoptosis, molecular modelling and ADME studies. Journal of Enzyme Inhibition and Medicinal Chemistry 38:1.
Read now
Read now
Tarfah Al-Warhi, Ahmed A. Al-Karmalawy, Ayman Abo Elmaaty, Maha A. Alshubramy, Marwa Abdel-Motaal, Taghreed A. Majrashi, Medhat Asem, Ahmed Nabil, Wagdy M. Eldehna & Marwa Sharaky. (2023) Biological evaluation, docking studies, and in silico ADME prediction of some pyrimidine and pyridine derivatives as potential EGFRWT and EGFRT790M inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 38:1, pages 176-191.
Read now
Read now
H. Peter Rodemann, Klaus Dittmann & Mahmoud Toulany. (2007) Radiation-induced EGFR-signaling and control of DNA-damage repair. International Journal of Radiation Biology 83:11-12, pages 781-791.
Read now
Read now
Articles from other publishers (50)
Mustafa A. Al-Qadhi, Heba Abdelrasheed Allam, Samar H. Fahim, Tawfeek A.A. Yahya & Fatma A.F. Ragab. (2023) Design and synthesis of certain 7-Aryl-2-Methyl-3-Substituted Pyrazolo{1,5-a}Pyrimidines as multikinase inhibitors. European Journal of Medicinal Chemistry 262, pages 115918.
Crossref
Crossref
Aisha Y. Hassan, Moshira A. El Deeb, Mona S. El-Zoghbi, Samiha A. El-Sebaey & Nada M. Mohamed. (2023) Novel thioxoimidazolidinone derivatives as dual EGFR and CDK2 inhibitors: Design, synthesis, anticancer evaluation with in silico study. Journal of Molecular Structure 1291, pages 136022.
Crossref
Crossref
Samia S. Hawas, Selwan M. El-Sayed, Perihan A. Elzahhar & Mohamed A. Moustafa. (2023) New 2-alkoxycyanopyridine derivatives as inhibitors of EGFR, HER2, and DHFR: Synthesis, anticancer evaluation, and molecular modeling studies. Bioorganic Chemistry, pages 106874.
Crossref
Crossref
Waleed A. Badawi, Mohamed Samir, Hazem M. Fathy, Tarek M. Okda, Mohamed H. Noureldin, Gamal M.K. Atwa & Omaima M. AboulWafa. (2023) Design, synthesis and molecular docking study of new pyrimidine-based hydrazones with selective anti-proliferative activity against MCF-7 and MDA-MB-231 human breast cancer cell lines. Bioorganic Chemistry 138, pages 106610.
Crossref
Crossref
Fiby N. Takla, Waleed A. Bayoumi, Shahenda M. El-Messery & Magda N. A. Nasr. (2023) Developing multitarget coumarin based anti-breast cancer agents: synthesis and molecular modeling study. Scientific Reports 13:1.
Crossref
Crossref
Shimaa A. Othman, Ola F. Abou‐Ghadir, Wafaa S. Ramadan, Yaser A. Mostafa, Raafat El‐Awady & Hajjaj H. M. Abdu‐Allah. (2023) The design, synthesis, biological evaluation, and molecular docking of new 5‐aminosalicylamide‐4‐thiazolinone hybrids as anticancer agents. Archiv der Pharmazie.
Crossref
Crossref
Noha H. Amin, Mohammed T. El-Saadi, Maha M. Abdel-Fattah, Asmaa A. Mohammed & Eman G. Said. (2023) Development of certain aminoquinazoline scaffolds as potential multitarget anticancer agents with apoptotic and anti-proliferative effects: Design, synthesis and biological evaluation. Bioorganic Chemistry 135, pages 106496.
Crossref
Crossref
Yu Cao, Xixuan Lu, Liping Fu, Tao Shi, Chong Zhang, Linghui Zeng, Jiankang Zhang, Jiaan Shao, Jianjun Xi, Zongfu Pan, Shourong Liu & Huajian Zhu. (2023) Exploration of novel dihydroquinoxalinone derivatives as EGFRL858R/T790M tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer. Bioorganic Chemistry 135, pages 106494.
Crossref
Crossref
Omaima M. AboulWafa, Hoda M.G. Daabees & Ahmed H. El-Said. (2023) Benzoxazole-appended piperidine derivatives as novel anticancer candidates against breast cancer. Bioorganic Chemistry 134, pages 106437.
Crossref
Crossref
Ashwag S. Alanazi, Tebyan O. Mirgany, Aisha A. Alsfouk, Nawaf A. Alsaif & Mohammed M. Alanazi. (2023) Antiproliferative Activity, Multikinase Inhibition, Apoptosis- Inducing Effects and Molecular Docking of Novel Isatin–Purine Hybrids. Medicina 59:3, pages 610.
Crossref
Crossref
Mohamed A. Sabry, Mariam A. Ghaly, Azza R. Maarouf & Hussein I. El-Subbagh. (2022) New thiazole-based derivatives as EGFR/HER2 and DHFR inhibitors: Synthesis, molecular modeling simulations and anticancer activity. European Journal of Medicinal Chemistry 241, pages 114661.
Crossref
Crossref
N. M. Fawzy, K. M. Ahmed, H. M. Abo-Salem & M. S. Aly. (2022) Novel Furochromone Derivatives of Potential Anticancer Activity Targeting EGFR Tyrosine Kinase. Synthesis and Molecular Docking Study. Russian Journal of Bioorganic Chemistry 48:4, pages 749-767.
Crossref
Crossref
Eman A. Sobh, Nadia A. Khalil, Samar I. Faggal & Marwa S. A. Hassan. (2022) New benzothienopyrimidine derivatives as dual EGFR/ARO inhibitors: Design, synthesis, and their cytotoxic effect on MCF‐7 breast cancer cell line. Drug Development Research 83:5, pages 1075-1096.
Crossref
Crossref
Maiiada Hassan Nazmy, Ramadan Ahmed Mekheimer, Mai E. Shoman, Mohamed Abo-Elsebaa, Mohamed Abd-Elmonem & Kamal Usef Sadek. (2022) Controlled microwave-assisted reactions: A facile synthesis of polyfunctionally substituted phthalazines as dual EGFR and PI3K inhibitors in CNS SNB-75 cell line. Bioorganic Chemistry 122, pages 105740.
Crossref
Crossref
Thoraya A. Farghaly, Eman M.H. Abbas, Amerah M. Al-Soliemy, Rehab Sabour & Mohamed R. Shaaban. (2022) Novel sulfonyl thiazolyl-hydrazone derivatives as EGFR inhibitors: Design, synthesis, biological evaluation and molecular docking studies. Bioorganic Chemistry 121, pages 105684.
Crossref
Crossref
Ashraf N. E. Hamed, Mohamed E. Abouelela, Ahmed E. El Zowalaty, Mohamed M. Badr & Mohamed S. A. Abdelkader. (2022)
Chemical constituents from
Carica papaya
Linn. leaves as potential cytotoxic, EGFR
wt
and aromatase (CYP19A) inhibitors; a study supported by molecular docking
. RSC Advances 12:15, pages 9154-9162.
Crossref
Crossref
Myra Elizabeth Conway. (2021) Emerging Moonlighting Functions of the Branched-Chain Aminotransferase Proteins. Antioxidants & Redox Signaling 34:13, pages 1048-1067.
Crossref
Crossref
Vincenza Ylenia Cusenza, Alessandra Bisagni, Monia Rinaldini, Chiara Cattani & Raffaele Frazzi. (2021) Copy Number Variation and Rearrangements Assessment in Cancer: Comparison of Droplet Digital PCR with the Current Approaches. International Journal of Molecular Sciences 22:9, pages 4732.
Crossref
Crossref
Abdalla R. Mohamed, Ahmed M. El Kerdawy, Riham F. George, Hanan H. Georgey & Nagwa M. Abdel Gawad. (2021) Design, synthesis and in silico insights of new 7,8-disubstituted-1,3-dimethyl-1H-purine-2,6(3H,7H)-dione derivatives with potent anticancer and multi-kinase inhibitory activities. Bioorganic Chemistry 107, pages 104569.
Crossref
Crossref
Adel S. El-Azab, Alaa A.-M. Abdel-Aziz, Nawaf A. AlSaif, Hamad M. Alkahtani, Mohammed M. Alanazi, Ahmad J. Obaidullah, Razan O. Eskandrani & Amal Alharbi. (2020) Antitumor activity, multitarget mechanisms, and molecular docking studies of quinazoline derivatives based on a benzenesulfonamide scaffold: Cell cycle analysis. Bioorganic Chemistry 104, pages 104345.
Crossref
Crossref
Omaima M. AboulWafa, Hoda M.G. Daabees & Waleed A. Badawi. (2020) 2-Anilinopyrimidine derivatives: Design, synthesis, in vitro anti-proliferative activity, EGFR and ARO inhibitory activity, cell cycle analysis and molecular docking study. Bioorganic Chemistry 99, pages 103798.
Crossref
Crossref
Wafaa A. Ewes, Mohammad A. Elmorsy, Shahenda M. El-Messery & Magda N.A. Nasr. (2020) Synthesis, biological evaluation and molecular modeling study of [1,2,4]-Triazolo[4,3-c]quinazolines: New class of EGFR-TK inhibitors. Bioorganic & Medicinal Chemistry 28:7, pages 115373.
Crossref
Crossref
A.- Mohsen M.E. Omar, Omaima M. AboulWafa, Mai S. El-Shoukrofy & Mai E. Amr. (2020) Benzoxazole derivatives as new generation of anti-breast cancer agents. Bioorganic Chemistry 96, pages 103593.
Crossref
Crossref
Kristin A. Giamanco & Russell T. Matthews. 2020. Tumor Microenvironment. Tumor Microenvironment
117
132
.
Eric H. Radany. 2017. Advances in Radiation Oncology. Advances in Radiation Oncology
239
253
.
Shyhmin Huang, H. Peter Rodemann & Paul M. Harari. 2016. Molecular Radio-Oncology. Molecular Radio-Oncology
45
87
.
Mahmoud Toulany. 2016. Strategies to Enhance the Therapeutic Ratio of Radiation as a Cancer Treatment. Strategies to Enhance the Therapeutic Ratio of Radiation as a Cancer Treatment
253
287
.
Mahmoud Toulany & H. Peter Rodemann. (2015) Phosphatidylinositol 3-kinase/Akt signaling as a key mediator of tumor cell responsiveness to radiation. Seminars in Cancer Biology 35, pages 180-190.
Crossref
Crossref
Elvis Boamah, Qudus Ibrahim, Lordcarse Kwinji, Ruchi Patel, Dolapo Ajayi & Michael Danquah. (2015) EGFR inhibitors in combination with cyclopamine as chemotherapeutic strategy for treating breast cancer. Synergy 2:2, pages 7-18.
Crossref
Crossref
Ann-Marie Broome, Gopal Ramamurthy, Kari Lavik, Alexander Liggett, Ian Kinstlinger & James Basilion. (2015) Optical Imaging of Targeted β-Galactosidase in Brain Tumors to Detect EGFR Levels. Bioconjugate Chemistry 26:4, pages 660-668.
Crossref
Crossref
Lina Wang, Bo Wei, Guozhang Hu, Le Wang, Ying Jin & Zhigang Sun. (2014) RETRACTED ARTICLE: Gene expression analyses to explore the biomarkers and therapeutic targets for gliomas. Neurological Sciences 36:3, pages 403-409.
Crossref
Crossref
Meng Wang, Patrick Maier, Frederik Wenz, Frank Anton Giordano & Carsten Herskind. (2013) Mitogenic signalling in the absence of epidermal growth factor receptor activation in a human glioblastoma cell line. Journal of Neuro-Oncology 115:3, pages 323-331.
Crossref
Crossref
Maite Verreault, Sherry A. Weppler, Amelia Stegeman, Corinna Warburton, Dita Strutt, Dana Masin & Marcel B. Bally. (2013) Combined RNAi-Mediated Suppression of Rictor and EGFR Resulted in Complete Tumor Regression in an Orthotopic Glioblastoma Tumor Model. PLoS ONE 8:3, pages e59597.
Crossref
Crossref
XIAOFENG DING, FANGLIANG ZHOU, FANGMEI WANG, ZIJIAN YANG, CHANG ZHOU, JIANLIN ZHOU, BO ZHANG, JUNMEI YANG, GUANGWEI WANG, ZHENG WEI, XIANG HU, SHUANGLIN XIANG & JIAN ZHANG. (2013) Eps8 promotes cellular growth of human malignant gliomas. Oncology Reports 29:2, pages 697-703.
Crossref
Crossref
Sandrine Eimer, Frédéric Dugay, Kelly Airiau, Tony Avril, Véronique Quillien, Marc-Antoine Belaud-Rotureau & Francis Belloc. (2012) Cyclopamine cooperates with EGFR inhibition to deplete stem-like cancer cells in glioblastoma-derived spheroid cultures. Neuro-Oncology 14:12, pages 1441-1451.
Crossref
Crossref
Kobra OmidfarZaynab Shirvani. (2012) Single Domain Antibodies: A New Concept for Epidermal Growth Factor Receptor and EGFRvIII Targeting. DNA and Cell Biology 31:6, pages 1015-1026.
Crossref
Crossref
ANGÉLIQUE GUILLAUDEAU, KARINE DURAND, HÉLÈNE RABINOVITCH-CHABLE, ISABELLE POMMEPUY, LAURA MESTUROUX, SANDRINE ROBERT, ALAIN CHAUNAVEL, JEAN-JACQUES MOREAU & FRANÇOIS LABROUSSE. (2012) Adult diffuse gliomas produce mRNA transcripts encoding EGFR isoforms lacking a tyrosine kinase domain. International Journal of Oncology 40:4, pages 1142-1152.
Crossref
Crossref
Kimberly Ng, Ryan Kim, Santosh Kesari, Bob Carter & Clark C. Chen. (2011) Genomic profiling of glioblastoma: convergence of fundamental biologic tenets and novel insights. Journal of Neuro-Oncology 107:1, pages 1-12.
Crossref
Crossref
Toshihisa Tsuruta, Yasuo Aihara, Hitoshi Kanno, Masakazu Funase, Toshihiko Murayama, Makiko Osawa, Hisaichi Fujii, Osami Kubo & Yoshikazu Okada. (2011) Shared molecular targets in pediatric gliomas and ependymomas. Pediatric Blood & Cancer 57:7, pages 1117-1123.
Crossref
Crossref
Shouqiang Cao, Chao Wang, Qian Zheng, Ying Qiao, Ke Xu, Tao Jiang & Anhua Wu. (2011) STAT5 regulates glioma cell invasion by pathways dependent and independent of STAT5 DNA binding. Neuroscience Letters 487:2, pages 228-233.
Crossref
Crossref
Sven R. Kantelhardt, Wouter Caarls, Anthony H. B. de Vries, Guy M. Hagen, Thomas M. Jovin, Walter Schulz-Schaeffer, Veit Rohde, Alf Giese & Donna J. Arndt-Jovin. (2010) Specific Visualization of Glioma Cells in Living Low-Grade Tumor Tissue. PLoS ONE 5:6, pages e11323.
Crossref
Crossref
Hui-Wen Lo, Xinyu Cao, Hu Zhu & Francis Ali-Osman. (2010) Cyclooxygenase-2 Is a Novel Transcriptional Target of the Nuclear EGFR-STAT3 and EGFRvIII-STAT3 Signaling Axes. Molecular Cancer Research 8:2, pages 232-245.
Crossref
Crossref
Dipti Mahajan & Richard A. Prayson. (2009) Repeated Molecular Testing in Gliomas. American Journal of Clinical Pathology 132:1, pages 118-124.
Crossref
Crossref
Angélique Guillaudeau, Karine Durand, Isabelle Pommepuy, Sandrine Robert, Alain Chaunavel, Sylvain Lacorre, Rafaël DeArmas, Sylvie Bourtoumieux, Mounira El Demery, Jean-Jacques Moreau & François Labrousse. (2009) Determination of EGFR Status in Gliomas. Applied Immunohistochemistry & Molecular Morphology 17:3, pages 220-226.
Crossref
Crossref
Donna J. Arndt-Jovin, Sven R. Kantelhardt, Wouter Caarls, Anthony H. B. de Vries, Alf Giese & Thomas M. Jovin. (2009) Tumor-Targeted Quantum Dots Can Help Surgeons Find Tumor Boundaries. IEEE Transactions on NanoBioscience 8:1, pages 65-71.
Crossref
Crossref
Andreas A. Argyriou, Anna Antonacopoulou, Gregoris Iconomou & Haralabos P. Kalofonos. (2009) Treatment options for malignant gliomas, emphasizing towards new molecularly targeted therapies. Critical Reviews in Oncology/Hematology 69:3, pages 199-210.
Crossref
Crossref
Costas G. Hadjipanayis. 2009. CNS Cancer. CNS Cancer
1105
1136
.
Hui-Wen Lo, Xinyu Cao, Hu Zhu & Francis Ali-Osman. (2008) Constitutively Activated STAT3 Frequently Coexpresses with Epidermal Growth Factor Receptor in High-Grade Gliomas and Targeting STAT3 Sensitizes Them to Iressa and Alkylators. Clinical Cancer Research 14:19, pages 6042-6054.
Crossref
Crossref
Hauke Busch, David Camacho‐Trullio, Zbigniew Rogon, Kai Breuhahn, Peter Angel, Roland Eils & Axel Szabowski. (2008) Gene network dynamics controlling keratinocyte migration. Molecular Systems Biology 4:1.
Crossref
Crossref
An Claes, Albert J. Idema & Pieter Wesseling. (2007) Diffuse glioma growth: a guerilla war. Acta Neuropathologica 114:5, pages 443-458.
Crossref
Crossref